A possible effect of methylphenidate on state anxiety: A single dose, placebo controlled, crossover study in a control group

Psychiatry Res. 2016 Jul 30:241:232-5. doi: 10.1016/j.psychres.2016.05.009. Epub 2016 May 11.

Abstract

Methylphenidate affects state-anxiety in ADHD patients. The current study examines the effect of Methylphenidate on state-anxiety in healthy subjects. In a cross-over, randomized, controlled, double-blind study, 36 healthy subjects received either Methylphenidate or placebo. As a group, no change in state-anxiety was detected with Methylphenidate. However, participants reporting higher anxiety levels experienced a significant and specific state-anxiety reduction following Methylphenidate. Moreover, a strong negative correlation was found between the initial-level of anxiety and net-change in state-anxiety. These changes were unrelated to self-perceived attention levels. Our results point to the state-dependent effects of Methylphenidate on anxiety.

Keywords: ADHD; Attention; Cognitive enhancer.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Anxiety Disorders / drug therapy*
  • Attention / drug effects
  • Central Nervous System Stimulants / therapeutic use*
  • Control Groups
  • Cross-Over Studies
  • Double-Blind Method
  • Female
  • Humans
  • Male
  • Methylphenidate / therapeutic use*
  • Middle Aged
  • Treatment Outcome

Substances

  • Central Nervous System Stimulants
  • Methylphenidate